Matches in SemOpenAlex for { <https://semopenalex.org/work/W3174442355> ?p ?o ?g. }
- W3174442355 endingPage "393" @default.
- W3174442355 startingPage "378" @default.
- W3174442355 abstract "The immune checkpoint blockade therapy has profoundly revolutionized the field of cancer immunotherapy. However, despite great promise for a variety of cancers, the efficacy of immune checkpoint inhibitors is still low in colorectal cancer (CRC). This is mainly due to the immunosuppressive feature of the tumor microenvironment (TME). Emerging evidence reveals that certain chemotherapeutic drugs induce immunogenic cell death (ICD), demonstrating great potential for remodeling the immunosuppressive TME. In this study, the potential of ginsenoside Rg3 (Rg3) as an ICD inducer against CRC cells was confirmed using in vitro and in vivo experimental approaches. The ICD efficacy of Rg3 could be significantly enhanced by quercetin (QTN) that elicited reactive oxygen species (ROS). To ameliorate in vivo delivery barriers associated with chemotherapeutic drugs, a folate (FA)-targeted polyethylene glycol (PEG)-modified amphiphilic cyclodextrin nanoparticle (NP) was developed for co-encapsulation of Rg3 and QTN. The resultant nanoformulation (CD-PEG-FA.Rg3.QTN) significantly prolonged blood circulation and enhanced tumor targeting in an orthotopic CRC mouse model, resulting in the conversion of immunosuppressive TME. Furthermore, the CD-PEG-FA.Rg3.QTN achieved significantly longer survival of animals in combination with Anti-PD-L1. The study provides a promising strategy for the treatment of CRC." @default.
- W3174442355 created "2021-07-05" @default.
- W3174442355 creator A5005645572 @default.
- W3174442355 creator A5012872280 @default.
- W3174442355 creator A5029125895 @default.
- W3174442355 creator A5035567860 @default.
- W3174442355 creator A5048662409 @default.
- W3174442355 creator A5059071043 @default.
- W3174442355 creator A5067673744 @default.
- W3174442355 creator A5074833470 @default.
- W3174442355 creator A5078087258 @default.
- W3174442355 creator A5078918307 @default.
- W3174442355 creator A5081976284 @default.
- W3174442355 date "2022-01-01" @default.
- W3174442355 modified "2023-10-18" @default.
- W3174442355 title "A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer" @default.
- W3174442355 cites W126188432 @default.
- W3174442355 cites W1455607549 @default.
- W3174442355 cites W1580919539 @default.
- W3174442355 cites W1843302206 @default.
- W3174442355 cites W1942176190 @default.
- W3174442355 cites W1965205681 @default.
- W3174442355 cites W1967329857 @default.
- W3174442355 cites W1969286776 @default.
- W3174442355 cites W1970914111 @default.
- W3174442355 cites W1977178308 @default.
- W3174442355 cites W1977315768 @default.
- W3174442355 cites W1987225988 @default.
- W3174442355 cites W1987331911 @default.
- W3174442355 cites W1992663209 @default.
- W3174442355 cites W1997787046 @default.
- W3174442355 cites W1999998145 @default.
- W3174442355 cites W2006302849 @default.
- W3174442355 cites W2013475854 @default.
- W3174442355 cites W2024007859 @default.
- W3174442355 cites W2033877575 @default.
- W3174442355 cites W2064055988 @default.
- W3174442355 cites W2064441112 @default.
- W3174442355 cites W2072171365 @default.
- W3174442355 cites W2091103707 @default.
- W3174442355 cites W2096439168 @default.
- W3174442355 cites W2100592123 @default.
- W3174442355 cites W2115624769 @default.
- W3174442355 cites W2120426523 @default.
- W3174442355 cites W2124427232 @default.
- W3174442355 cites W2127152090 @default.
- W3174442355 cites W2137823095 @default.
- W3174442355 cites W2142153200 @default.
- W3174442355 cites W2152315865 @default.
- W3174442355 cites W2157096314 @default.
- W3174442355 cites W2158785129 @default.
- W3174442355 cites W2162695817 @default.
- W3174442355 cites W2324107401 @default.
- W3174442355 cites W2389366201 @default.
- W3174442355 cites W2436942341 @default.
- W3174442355 cites W2466093998 @default.
- W3174442355 cites W2488042065 @default.
- W3174442355 cites W2536322725 @default.
- W3174442355 cites W2560759086 @default.
- W3174442355 cites W2572946219 @default.
- W3174442355 cites W2585743330 @default.
- W3174442355 cites W2644529227 @default.
- W3174442355 cites W2743818239 @default.
- W3174442355 cites W2748137738 @default.
- W3174442355 cites W2752326209 @default.
- W3174442355 cites W2770647635 @default.
- W3174442355 cites W2783507731 @default.
- W3174442355 cites W2791512052 @default.
- W3174442355 cites W2794137041 @default.
- W3174442355 cites W2803757775 @default.
- W3174442355 cites W2807361338 @default.
- W3174442355 cites W2885761217 @default.
- W3174442355 cites W2886471216 @default.
- W3174442355 cites W2887577080 @default.
- W3174442355 cites W2896573586 @default.
- W3174442355 cites W2900596005 @default.
- W3174442355 cites W2905299787 @default.
- W3174442355 cites W2908838385 @default.
- W3174442355 cites W2911512759 @default.
- W3174442355 cites W2914691849 @default.
- W3174442355 cites W2914723294 @default.
- W3174442355 cites W2936050665 @default.
- W3174442355 cites W2941897681 @default.
- W3174442355 cites W2950071015 @default.
- W3174442355 cites W2958502160 @default.
- W3174442355 cites W2960598474 @default.
- W3174442355 cites W2982319722 @default.
- W3174442355 cites W2983363499 @default.
- W3174442355 cites W2992166237 @default.
- W3174442355 cites W2993602470 @default.
- W3174442355 cites W3006101499 @default.
- W3174442355 cites W3007737669 @default.
- W3174442355 cites W3011030655 @default.
- W3174442355 cites W3016231863 @default.
- W3174442355 cites W3016713923 @default.
- W3174442355 cites W3026546957 @default.
- W3174442355 cites W3107376610 @default.
- W3174442355 cites W3108507086 @default.